Ngomhla ziyisi-9 kuNhlaba, 2022, isimemezelo sangempela se-FDA safaka kuhlu lwe-Glanbia Performance Nutrition (Manufacturing) Inc. phakathi kwezinkampani ezithole izincwadi eziyisixwayiso.Esimemezelweni esibuyekeziwe esithunyelwe ngoMeyi 10, 2022, i-Glanbia yasuswa esimemezelweni se-FDA futhi ayisafakwa ohlwini lwezinkampani ezithola izincwadi zesexwayiso.
I-Silver Spring, MD—I-Food and Drug Administration (FDA) ikhiphe izincwadi eziyisixwayiso eziya ezinkampanini eziyi-11 ngokuthengisa izithasiselo zokudla ezonakele.I-FDA ibike ukuthi izincwadi zithunyelwa ngezizathu ezahlukahlukene, okuhlanganisa:
Ezinye izithasiselo ziqukethe izithako zokudla ezintsha (NDIs) lapho i-ejensi ingazange ithole izaziso ezidingekayo ze-NDI emakethe.
Ezinye izithasiselo nazo ziyizidakamizwa, naphezu kokuntula ukuvunywa, ngoba zihloselwe ukusetshenziswa ekwelapheni, ekunciphiseni, ekwelapheni, noma ekuvimbeleni izifo.Ngaphansi kwe-Federal Food, Drug, and Cosmetic Act, imikhiqizo ehloselwe ukuxilonga, ukwelapha, ukwelapha, ukunciphisa, noma ukuvimbela isifo izidakamizwa futhi ingaphansi kwezidingo ezisebenza emithini, ngisho noma ibhalwe njengezithako zokudla, futhi ngokuvamile idinga ukugunyazwa kwangaphambili kwe-FDA.
Ezinye izithasiselo zimakwe njengezithasiselo zokudla ezingaphephile.
Izincwadi zesixwayiso zithunyelwe ku:
- Izithasiselo Zokudla Okuthuthukisiwe, LLC
- Imikhiqizo Yokudla Okukhethekile, LLC (Black Dragon Labs)
- Ama-Assault Labs
- I-IronMag Labs
- I-Killer Labz (Performax Labs Inc)
- Qedela Nutrition LLC
- I-Max Muscle
- I-New York Nutrition Company (i-American Metabolix)
- Ukuthengiswa Komsoco kanye Nesevisi Yekhasimende LLC
- Izindleko zamasheya Steel Supplements, Inc.
I-FDA ibike ukuthi izithasiselo ezithengiswa yizinkampani ezibalwe ngenhla ziqukethe okukodwa noma ngaphezulu kwalokhu okulandelayo:
- 5-alpha-hydroxy-laxogenin
- i-higenamine
- i-higenamine HCl
- i-hordenine
- i-hordenine HCl
- i-octopamine.
I-FDA yaphawula ukuthi iphakamise ukukhathazeka ngezithako ezimbalwa zalezi zithako, futhi yakhomba emiphumeleni emibi engaba khona ye-higenamine ohlelweni lwenhliziyo nemithambo yegazi.
I-ejensi yengeze ngokuthi ayikahloli ukuthi imikhiqizo engagunyaziwe engaphansi kwalolu chungechunge lwakamuva lwezinhlamvu eziyisixwayiso iyasebenza yini ekuhlosweni kwayo, ukuthi ingakanani umthamo ofanele, ingasebenzisana kanjani nezidakamizwa ezigunyazwe i-FDA noma ezinye izinto, noma ukuthi babe nemiphumela emibi eyingozi noma okunye ukukhathazeka ngokuphepha.
Izinkampani ezixwayisisiwe zinezinsuku zokusebenza eziyi-15 zokutshela i-FDA ukuthi lezi zinkinga zizosingathwa kanjani, noma ukunikeza ukucabanga nolwazi olusekelayo oluchaza ukuthi kungani imikhiqizo ingaphuli umthetho.Ukwehluleka ukubhekana nalolu daba ngendlela efanele kungase kuphumele ekuthathweni kwezomthetho, okuhlanganisa ukushaqwa komkhiqizo kanye/noma ukuyalelwa.
Lo mjikelezo wakamuva wezixwayiso, owathunyelwa ngoMeyi 9, uza ngemuva kwezinsuku ezimbalwa i-FDA ithumele izincwadi zesexwayiso ezinkampanini ezinhlanu ngokuthengisa imikhiqizo ebhalwe ukuthi iqukethe i-delta-8 tetrahydrocannabinol (delta-8 THC) ngezindlela ezephula i-Federal Food, Drug, kanye ne-Cosmetic Act (FD&C Act).Lezo zinhlamvu ziphawula okokuqala ngqa izexwayiso ezikhishelwe emikhiqizweni equkethe i-delta-8 THC, i-FDA ithe inemiphumela ethinta ingqondo kanye nokudakayo futhi ingaba yingozi kubathengi.
Isikhathi sokuthumela: May-19-2022